Topic: Pfizer Inc.
(Reuters) - Pfizer Inc and Teva Pharmceutical Industries Ltd were sued by Walgreen Co and four other large retailers, accused of violating U.S. antitrust law by conspiring to keep generic versions of a popular antidepressant off the shelves.Walgreen, Kroger Co, Safeway Inc, ...
NEW YORK (Reuters) - Pfizer Inc reached a settlement with Dr. Reddy's Laboratories , an Indian drugmaker that has been fighting in court to launch cheaper generic forms of Pfizer's blockbuster cholesterol fighter, the companies said on Wednesday .Dr. Reddy's in 2009 ...
BOSTON (Reuters) - Pfizer Inc said on Monday it won a patent infringement case against the U.S. unit of Teva Pharmaceuticals Industries Ltd, preventing Teva from launching a generic version of Pfizer's erectile dysfunction drug Viagra until October 2019.Pfizer, the world's biggest ...
NEW YORK (Reuters) - Pfizer Inc may have won over shareholders with its recent decision to pare back research and development spending but could be shortchanging them in the long run, according to its former research chief.Pfizer, the world's largest drugmaker, said ...
WASHINGTON (Reuters) - Pfizer Inc has agreed to suspend U.S. sales of a popular poultry drug after a study found the drug increased levels of a carcinogen in chickens, U.S. health officials said on Wednesday.A study from the Food and Drug Administration ...
LONDON (Reuters) - Prompted by the soaring cost of developing and marketing their medicines, drug companies are embracing the Internet in a bid to drive down costs.The hope is that digital tools will not only make them more efficient, but also smarter ...
NEW YORK (Reuters) - Pfizer Inc is expected to report slightly lower quarterly earnings on Tuesday, but investors will be more focused on any signs the world's biggest drugmaker will further shrink itself to weather looming competition from generic drugs for its ...
LONDON (Reuters) - Roche is set to kick off the Big Pharma reporting season with a fall in sales on Thursday as a strong Swiss franc, weak demand for top-selling cancer drug Avastin and lack of Tamiflu revenue take their toll.The absence ...
NEW YORK (Reuters) - Pfizer Inc said it struck a deal to sell its Capsugel unit, the world's largest maker of hard capsules, to private equity firm KKR & Co for nearly $2.38 billion.Pfizer, which said in October it was exploring the ...
WASHINGTON (Reuters) - Health regulators want more data on Protalix Biotherapeutics Inc and Pfizer Inc's experimental drug for Gaucher disease before deciding whether to approve the therapy for patients with the rare genetic disorder.News of the delay sent Protalix shares tumbling more ...